Vaccine

Details for Australian Patent Application No. 2010264686 (hide)

Owner GlaxoSmithKline Biologicals S.A. ID Biomedical Corporation of Quebec

Inventors Blais, Normand; Rheault, Patrick; VanScherpenzeel-Thim, Virginie; Vassilev, Ventzislav

Agent Davies Collison Cave

Pub. Number AU-A-2010264686

PCT Pub. Number WO2010/149743

Priority 61/219,958 24.06.09 US

Filing date 24 June 2010

Wipo publication date 29 December 2010

International Classifications

C07K 14/115 (2006.01) Peptides having more than 20 amino acids

A61K 39/155 (2006.01) Medicinal preparations containing antigens or antibodies - Paramyxoviridae, e.g. parainfluenza virus

C07K 14/135 (2006.01) Peptides having more than 20 amino acids

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/149743 Priority application(s): WO2010/149743

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010264688-Recombinant RSV antigens

2010264685-Method of dissociating an organoborane-amine complex